CWM
ABBV icon

Centurion Wealth Management’s AbbVie ABBV Stock Holding History

Centurion Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Buy
2,765
+124
+5% +$26.7K 0.17% 121
2026
Q1 		$574K Buy
2,641
+345
+15% +$76.5K 0.13% 145
2025
Q4 		$525K Sell
2,296
-72
-3% -$16.4K 0.11% 158
2025
Q3 		$548K Buy
2,368
+862
+57% +$176K 0.12% 146
2025
Q2 		$280K Buy
1,506
+123
+9% +$22.9K 0.08% 182
2025
Q1 		$246K Hold
1,383
– – 0.08% 180
2024
Q4 		$246K Sell
1,383
-15
-1% -$2.76K 0.08% 180
2024
Q3 		$276K Buy
+1,398
New +$261K 0.09% 164
2024
Q1 		$263K Sell
1,444
-9
-0.6% -$1.55K 0.1% 150
2023
Q4 		$225K Sell
1,453
-172
-11% -$25.1K 0.1% 148
2023
Q3 		$242K Buy
1,625
+10
+0.6% +$1.47K 0.12% 121
2023
Q2 		$218K Buy
1,615
+1
+0.1% +$147 0.1% 140
2023
Q1 		$257K Sell
1,614
-53
-3% -$8.1K 0.13% 120
2022
Q4 		$269K Buy
+1,667
New +$256K 0.15% 114

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Centurion Wealth Management's ABBV Position: Q2 2026 in Review

Centurion Wealth Management increased its AbbVie (ABBV) stake by 4.7% in Q2 2026, buying an estimated $26.7K and bringing the position to 2,765 shares worth $696K. The position accounts for 0.17% of the portfolio, ranked #121.

Centurion Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Centurion Wealth Management held 2,765 shares of AbbVie worth $696K as of Q2 2026.
  • Centurion Wealth Management bought 124 AbbVie shares in Q2 2026, an estimated $26.7K.
  • AbbVie made up 0.17% of Centurion Wealth Management's portfolio in Q2 2026, its #121 holding.
  • Centurion Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.